''Recent treatment guidelines from the Japanese Urological Society [68] refer to the efficacy demonstrated with docetaxel 70-75 mg/m 2 every 3 weeks in the TAX 327 trial [5] and 60 mg/m 2 every 3 weeks in combination with estramustine in the SWOG 9916 trial.
[21] '' has now been corrected as follows:
''Recent treatment guidelines from the Japanese Urological Association [68] refer to the efficacy demonstrated with docetaxel 70-75 mg/m 2 every 3 weeks in the Japanese phase II study [30] and TAX 327 trial, [5] and docetaxel 60 mg/m 2 every 3 weeks in combination with estramustine in the SWOG 9916 trial.
[21] ''
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